Targeted News Service

FDA Issues Notice on Zantac Injection Safety Status
December 21, 2025

WASHINGTON, Dec. 21 (TNSFR) -- The U.S. Department of Health and Human Services Food and Drug Administration issued a notice determining that Zantac injection was not withdrawn from sale for reasons of safety or effectiveness, provided manufacturing meets specific impurity limits. This ruling clears a path for pharmaceutical companies to seek approval for generic versions of the drug.

Zantac injection, used to treat ulcers and hypersecretory conditions in hospitalized patients, was . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form